In the article “Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients” by McCormack et al.,1 the European Union's Horizon 2020 Research and Innovation Programme was inadvertently omitted from the Study Funding acknowledgment. This project has received funding from the European Union's Horizon 2020 Research and Innovation Programme under the Marie Skłodowska-Curie grant agreement no. 751761. The authors regret the omission.
Reference
- 1.McCormack M, Hongsheng G, Ingason A, et al. Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients. Neurology 2018;90:e332–e341. [DOI] [PMC free article] [PubMed] [Google Scholar]